Abstract

Source Citation Parkinson's Disease Research Group in the United Kingdom. Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Par...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
-
BMJ (Clinical research ed.) | VOL. 307
--
21 Aug 1993
Piecing together the puzzle of progression and mortality in Parkinson's disease
Connie Marras ... David Oakes
British journal of clinical pharmacology | VOL. 74
Connie Marras, et. al.Connie Marras ... David Oakes
10 Jul 2012
Early treatment of Parkinson's disease. Open studies are unreliable.
V Myllyla ... E Heinonen
BMJ (Clinical research ed.) | VOL. 308
V Myllyla, et. al.V Myllyla ... E Heinonen
22 Jan 1994
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.
P Jenner ... A H V Schapira
Annals of neurology | VOL. Suppl 32
P Jenner, et. al.P Jenner ... A H V Schapira
01 Jan 1992
View more papers

More From: ACP Journal Club

Paper Title
Journal
Date
Author
Heparin prophylaxis did not increase mortality and was beneficial in adults with sepsis receiving drotrecogin alfa
Deborah Cook
ACP Journal Club | VOL. 148
Deborah CookDeborah Cook
01 Mar 2008
Review: Long-acting inhaled therapies and pulmonary rehabilitation are effective in stable COPD
Christine Mcdonald
ACP Journal Club | VOL. 148
Christine McdonaldChristine Mcdonald
01 Mar 2008
Review: Calcium supplementation, with or without vitamin D, prevents osteoporotic fractures in people ≥ 50 years of age
Sophie A Jamal ... Helen Emanoilidis
ACP Journal Club | VOL. 148
Sophie A Jamal, et. al.Sophie A Jamal ... Helen Emanoilidis
01 Mar 2008
Pharmacogenetic-guided and standard dosing did not differ for out-of-range INRs in patients initiating warfarin therapy
David Garcia
ACP Journal Club | VOL. 148
David GarciaDavid Garcia
01 Mar 2008
View more papers